BaroPace, Inc.

Issaquah, WA · Founded 2018 · Medtech · Private

Baroreflex activation device that modulates blood pressure through electrical stimulation of carotid baroreceptors

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · baropace.com

Sector
Medtech
Headquarters
Issaquah, WA
Founded
2018
Latest Form D
$365K, Sep 2024
Total capital
$940K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$940K
2 Form D · last Sep 2024
25 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
5
35 pending · first 2025
Rank in peer group#304 of 1112

Capital timeline

20202021202220232024FEDERAL ↑EQUITY ↓Cumulative $940K1st Form D$575K2nd Form D$365K
20202021202220232024FEDERAL ↑EQUITY ↓Cumulative $940K1st Form D$575K2nd Form D$365K

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$365K
  • Private capital raisedForm D · SEC · 1st filing$575K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#304 · top 27%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Bradley BurnamDirectorNamed in SEC Form D filings
  • Eli GangDirector, PromoterNamed in SEC Form D filings
  • Jessica BurnamExecutive Officer, PromoterNamed in SEC Form D filings
  • Michael BurnamExecutive Officer, DirectorNamed in SEC Form D filings
  • Mike CoyleDirectorNamed in SEC Form D filings

What it has protected

USPTO · 5 granted of 40
Show all 40 patent records
  • Systems And Methods For State Machine Selection For PacingOct 20, 2026 · US 12,766,326Granted
  • Method Of Treating Drug Resistant Hypertension And Heart Failure With Preserved Ejection Fraction By Combined Drug Treatment With Baropacing And Beta BlockersSep 1, 2026 · US 12,722,014Granted
  • Method Using Trend Analysis For Cardiac Treatment With Calibrated And Positionally Corrected Blood Pressure Watches, Pressure-pace Algortihms, Artificial Intelligence And Thoracic Electrical BioimpedanceJul 28, 2026 · US 12,691,286Granted
  • Intelligently, Continuously And Physiologically Controlled Pacemaker And Method Of Operation Of The SameJan 1, 2026 · Application 19318918Pending
  • Systems And Methods For Biomarker-based PacingDec 4, 2025 · Application 19134051Pending
  • Systems And Methods For Determining Systemic Vascular Resistance Using BioimpedanceDec 4, 2025 · Application 18992845Pending
  • An Intelligently, Continuously And Physiologically Controlled Pacemaker And Method Of Operation Of The SameSep 30, 2025 · US 12,427,321Granted
  • Systems And Methods For Determining Systemic Vascular Resistance Using PhotoplethysmographySep 25, 2025 · Application 18992847Pending
  • Method Of Treatment Of Drug Resistant HypertensionJul 8, 2025 · US 12,350,495Granted
  • Method Of Treatment Of Drug Resistant HypertensionJul 3, 2025 · Application 19081840Pending
  • Systems And Methods For State Machine Selection For PacingMay 29, 2025 · Application 18840812Pending
  • Systems And Methods For Blood Pressure Device CalibrationNov 21, 2024 · Application 18571009Pending
  • Systems And Methods For Cardiac Pacing Using Beta BlockersOct 17, 2024 · Application 18682569Pending
  • System And Method For Non-invasive Autonomic Nerve Activity Monitoring Using Artificial IntelligenceSep 12, 2024 · Application 18258475Pending
  • Method Of Treating Drug Resistant Hypertension And Heart Failure With Preserved Ejection Fraction By Combined Drug Treatment With Baropacing And Beta BlockersJan 18, 2024 · Application 18256841Pending
  • Method Using Trend Analysis For Cardiac Treatment With Calibrated And Positionally Corrected Blood Pressure Watches, Pressure-pace Algortihms, Artificial Intelligence And Thoracic Electrical BioimpedanceNov 9, 2023 · Application 18042708Pending
  • Method And Apparatus For Treatment Of Drug Resistant Hypertension Associated With Impaired Left Ventricular Function And Bradycardia Using A Cardiac PacemakerSep 8, 2022 · Application 17282658Pending
  • Methods And Systems For Natriuretic Peptide Based PacingApplication 63385935Pending
  • Systems And Methods For Cardiac Pacing Using Beta BlockersApplication PCTUS2022041289Pending
  • Systems And Methods For Determining Systemic Vascular Resistance Using PhotoplethysmographyApplication 63368316Pending
  • Systems And Methods For Determining Systemic Vascular Resistance Using BioimpedanceApplication 63368318Pending
  • Systems And Methods For Blood Pressure Device CalibrationApplication PCTUS2022072989Pending
  • Systems And Methods For Blood Pressure Device CalibrationApplication PCTUS2022072866Pending
  • Systems And Methods For State Machine Selection For PacingApplication 63268554Pending
  • Beta Blockers And BaropacingApplication 63266387Pending
  • A Method Of Treating Drug Resistant Hypertension And Heart Failure With Preserved Ejection Fraction By Combined Drug Treatment With Baropacing And Beta BlockersApplication PCTUS2021059557Pending
  • System And Method For Non-invasive Autonomic Nerve Activity Monitoring Using Artificial IntelligenceApplication PCTUS2021058821Pending
  • Beta Blockers And BaropacingApplication 63237029Pending
  • A Method Using Trend Analysis For Cardiac Treatment With Calibrated And Positionally Corrected Blood Pressure Watches, Pressure-pace Algorithms, Artificial Intelligence And Thoracic Electrical BioimpedanceApplication PCTUS2021042622Pending
  • Method And Apparatus For The Real-time Periodic Calibration Of An Indirect Blood Pressure Measuring Device Utilizing A Direct Method Of Blood Pressure Measurement As The Source Of CalibrationApplication 63212012Pending
  • Systems And Methods For Pacing Based On Pulse PressureApplication PCTUS2025047133Pending
  • System And Method For Non-invasive Autonomic Nerve Activity Monitoring Using Artificial IntelligenceApplication 63150480Pending
  • System And Method For Non-invasive Autonomic Nerve Activity Monitoring Using Artificial IntelligenceApplication 63128537Pending
  • Method Of Treatment Of Drug Resistant Hypertension By Electrically Stimulating The Right Atrium To Create Inhibition Of The Autonomic Nervous SystemApplication PCTUS2020044784Pending
  • A Method And Apparatus For Treatment Of Drug Resistant Hypertension Associated With Impaired Left Ventricular Function And Bradycardia Using A Cardiac PacemakerApplication PCTUS2019059703Pending
  • Systems And Methods For Managing Battery Drain In A Pacing DeviceApplication 19511334Pending
  • System And Method For Non-invasive Autonomic Nerve Activity Monitoring Using Artificial IntelligenceApplication 63166185Pending
  • Systems For Pacing Rate ProgrammingApplication 19152134Pending
  • Systems And Methods For Pacing Rate ProgrammingApplication PCTUS2025035847Pending
  • Systems And Methods For Pacing Based On Pulse PressureApplication 63701123Pending
  • QT MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
  • TeraBAT, Inc.Similar federal contract value in Medtech · null in contracts
  • Conavi Medical Corp.Similar federal contract value in Medtech · null in contracts
  • PrognomIQ, Inc.Similar federal contract value in Medtech · null in contracts
  • Exactics, Inc.Similar federal contract value in Medtech · null in contracts
  • Unlearn.ai, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .